uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Change in Account Payables (2016 - 2026)

uniQure (QURE) posted quarterly Change in Account Payables of $625000.0 for Q2 2026, up 406.37% year-over-year from $123426.9 in Q2 2025, and up 212.21% quarter-over-quarter from -$557000.0 in Q1 2026.

Analysis

uniQure (QURE) Change in Account Payables (2016 - 2026) Analysis & Trends

uniQure's Change in Account Payables history runs 11 years deep, the most recent figure standing at $625000.0 for Q2 2026.

  • In Q2 2026, Change in Account Payables rose 406.37% year-over-year to $625000.0; the TTM figure through Jun 2026 stood at -$302000.0 (down 135.87% YoY), while the FY2025 annual figure was -$2.7 million, down 275.46% from the prior year.
  • Change in Account Payables for Q2 2026 stood at $625000.0, up from -$557000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $7.3 million in Q1 2022, with the low at -$3.6 million in Q3 2023.
  • The 5-year median for Change in Account Payables is $61000.0 (2022), against an average of $221666.7.
  • The sharpest annual moves came in 2024 and 2026: Change in Account Payables slumped 304.45% in 2024, then soared 406.37% in 2026.
  • uniQure's Change in Account Payables stood at $4.7 million in 2022, then sank by 86.94% to $615000.0 in 2023, then surged by 230.41% to $2.0 million in 2024, then slumped by 150.15% to -$1.0 million in 2025, then soared by 161.33% to $625000.0 in 2026.
  • Business Quant data shows QURE's Change in Account Payables at $625000.0 in Q2 2026, -$557000.0 in Q1 2026, and -$1.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 625,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 625,000.00
Mar 31, 2026 -557,000.00
Dec 31, 2025 -1.02 Mn
Sep 30, 2025 649,000.00
Jun 30, 2025 -204,000.00
Mar 31, 2025 -2.09 Mn
Dec 31, 2024 2.03 Mn
Sep 30, 2024 1.11 Mn
Jun 30, 2024 -918,000.00
Mar 31, 2024 -701,000.00
Dec 31, 2023 615,000.00
Sep 30, 2023 -3.57 Mn
Jun 30, 2023 449,000.00
Mar 31, 2023 -1.66 Mn
Dec 31, 2022 4.71 Mn
Sep 30, 2022 -3.10 Mn
Jun 30, 2022 326,000.00
Mar 31, 2022 7.31 Mn
Dec 31, 2021 -2.73 Mn
Sep 30, 2021 -8.44 Mn